Premier Perspectives The blog for insider insights in clinical development Clinical Research: Phase 1 - Phase 4 Realizing the Full Value of Patient Centricity in Rare Disease: 5 Ways to Maximize Your Engagement Efforts By Kris O'Brien March 27, 2023 Featured Posts Clinical ResearchPhase 1 - Phase 4 Charting the Path: How Patient and Caregiver Journeys Guide Rare Disease Study Design By Kris O'Brien February 15, 2023 Clinical ResearchPhase 1 - Phase 4 7 Tips for Designing and Operationalizing Rare Disease Natural History Studies By Kris O'Brien June 27, 2022 Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 How to Use Patient Registries and Natural History Studies in Rare Disease Development By Kris O'Brien June 17, 2022 × ALSO OF INTERESTKey Considerations When Designing a Phase 1...7 Questions About Clinical Evaluations for MDRDesigning Pediatric Analgesic Treatment...
